Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats

Alcoholism: Clinical and Experimental Research

Volumn 31, Issue 11, 2007, Pages 1900-1907

  Hargreaves, Garth A ^a   McGregor, Iain S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Alcohol; Bipolar Disorder (Depression); GABA; Topiramate (Topamax); Wistar rat

Indexed keywords

DESIPRAMINE; NALOXONE; TOPIRAMATE;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COPING BEHAVIOR; DRUG EFFECT; DRUG MECHANISM; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MAZE TEST; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; FRUCTOSE; MALE; MAZE LEARNING; MOTIVATION; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR; SWIMMING;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 35349012172     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2007.00485.x     Document Type: Article

References (43)

1. Alaverdashvili M, Kubova H, Mares P (2005) Motor performance and behavior of immature rats are not compromised by a high dose of topiramate. Epilepsy Behav 7 : 222 230.
2. Bahk WM, Shin YC, Woo JM, Yoon BH, Lee JS, Jon DI, Chung SK, Choi SK, Paik IH, Pae CU (2005) Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study. Prog Neuropsychopharmacol Biol Psychiatry 29 : 115 121.
3. Berlant J, van Kammen DP (2002) Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry 63 : 15 20.
4. Bobes J, Carreno JE, Gutierrez CE, San Narciso GI, Antuna MJ, Diaz T, Fernandez JJ, Cerceda A, Alvarez CE, Marina P, Garcia-Garcia M (2004) Study of effectiveness of craving control with topiramate in patients with substance dependence disorders. Actas Esp Psiquiatr 32 : 299 306.
5. Cagetti E, Baicy KJ, Olsen RW (2004) Topiramate attenuates withdrawal signs after chronic intermittent ethanol in rats. Neuroreport 15 : 207 210.
6. Choi EA, Ki SW, Kim SE, Kim JW, Park JK (2005) The efficacy and safety of topiramate in the treatment of alcohol withdrawal. J Korean Neuropsychiatr Assoc 44 : 328 333.
7. Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29 : 547 569.
8. Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacologia 121 : 66 72.
9. Escher T, Mittleman G (2006) Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone. Addict Biol 11 : 55 63.
10. Gabriel KI, Cunningham CL (2005) Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice. Alcohol Clin Exp Res 29 : 75 80.
11. Gallate JE, McGregor IS (1999) The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology 142 : 302 308.
12. Gardell LR, Hubbell CL, Reid LD (1996) Naltrexone persistently reduces rats' intake of a palatable alcoholic beverage. Alcohol Clin Exp Res 20 : 584 588.
13. Gibbs JW III., Sombati S, DeLorenzo RJ, Coulter DA (2000) Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41 (Suppl. 1 S10 S16.
14. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61 : 807 816.
15. Gremel CM, Gabriel KI, Cunningham CL (2006) Topiramate does not affect the acquisition or expression of ethanol conditioned place preference in DBA/2J or C57BL/6J mice. Alcohol Clin Exp Res 30 : 783 790.
16. Gryder DS, Rogawski MA (2003) Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci 23 : 7069 7074.
17. Heyser CJ, Moc K, Koob GF (2003) Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology 28 : 1463 1471.
18. Heyser CJ, Schulteis G, Durbin P, Koob GF (1998) Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18 : 125 133.
19. Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54 : 21 30.
20. Holter SM, Spanagel R (1999) Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology 145 : 360 369.
21. Johnson BA (2004) Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study. Alcohol Clin Exp Res 28 : 1137 1144.
22. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361 : 1677 1685.
23. Khan S, Liberzon I (2004) Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD. Psychopharmacology 172 : 225 229.
24. Kushner SF, Khan A, Lane R, Olson WH (2006) Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Bipolar Disord 8 : 15 27.
25. McGregor IS, Gallate JE (2004) Rats on the grog: novel pharmacotherapies for alcohol craving. Addict Behav 29 : 1341 1357.
26. McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH (2002) Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord 43 : 207 213.
27. McIntyre RS, Riccardelli R, Binder C, Kusumakar V (2005) Open-label adjunctive topiramate in the treatment of unstable bipolar disorder. Can J Psychiatry 50 : 415 422.
28. Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS (2001) Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). Eur J Pharmacol 433 : 91 99.
29. Nickel C, Lahmann C, Tritt K, Muehlbacher M, Kaplan P, Kettler C, Krawczyk J, Loew TH, Rother WK, Nickel MK (2005) Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study. J Affect Disord 87 : 243 252.
30. Phillips TJ, Wenger CD, Dorow JD (1997) Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6 J mice. Alcohol Clin Exp Res 21 : 691 702.
31. Richard D, Ferland J, Lalonde J, Samson P, Deshaies Y (2000) Influence of topiramate in the regulation of energy balance. Nutrition 16 : 961 966.
32. Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, Li T-K (2002) Effects of ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: I. Periadolescent exposure. Alcohol Clin Exp Res 26 : 1632 1641.
33. Rosenfeld WE (1997) Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther 19 : 1294 1308.
34. Shank RP, Gardocki JF, Vaught JL, Davis CB, Schupsky JJ, Raffa RB, Dodgson SJ, Nortey SO, Maryanoff BE (1994) Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia 35 : 450 460.
35. Skradski S, White HS (2000) Topiramate blocks kainate-evoked cobalt influx into cultured neurons. Epilepsia 41 (Suppl. 1 S45 S47.
36. Suppes T (2002) Review of the use of topiramate for treatment of bipolar disorders. J Clin Psychopharmacol 22 : 599 609.
37. Taverna S, Sancini G, Mantegazza M, Franceschetti S, Avanzini G (1999) Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. J Pharmacol Exp Ther 288 : 960 968.
38. Tucker P, Trautman RP, Wyatt DB, Thompson J, Wu S-C, Capece JA, Rosenthal NR (2007) Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 68 : 201 206.
39. Vasudev K, Macritchie K, Geddes J, Watson S, Young A (2006) Topiramate for acute affective episodes in bipolar disorder. Cochrane Database Syst Rev 1 : CD003384.
40. Weiss F, Mitchiner M, Bloom FE, Koob GF (1990) Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharmacology 101 : 178 186.
41. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH (1997) Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 28 : 167 179.
42. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH (2000) Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 41 (Suppl. 1 S17 S20.
43. World Health Organization (2004) Global Status Report on Alcohol, pp 1 94. Department of Mental Health and Substance Abuse, Geneva.